In this pharmacodynamic study we analyzed liver tissue and vWAT obtained during bariatric surgery from short term UDCA treated and untreated morbidly obese NAFLD patients leading to decreased FXR activity, stimulated cholesterol and BA synthesis, hepatic lipid accumulation and altered lipid conversion in vWAT. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.